US Patent Issued to SANDOZ on March 31 for "Crystalline forms of an orally available, selective kit and PDGFR kinase inhibitor" (Austrian Inventors)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,590,095, issued on March 31, was assigned to SANDOZ AG (Basel, Switzerland).

"Crystalline forms of an orally available, selective kit and PDGFR kinase inhibitor" was invented by Verena Adamer (Kundl, Austria), Andrea Thaler (Kundl, Austria) and Erwin Schreiner (Kundl, Austria).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to crystalline avapritinib, polymorphs and hydrates thereof as well as to processes for their preparation. Furthermore, the invention relates to a pharmaceutical composition comprising crystalline avapritinib and at least one pharmaceutically acceptable excipient. The pharmaceutical composition of the pre...